Skip to main content
Top
Published in: Journal of Gastroenterology 7/2021

Open Access 01-07-2021 | Endoscopy | Original Article—Alimentary Tract

Composite detection rate as an upper gastrointestinal endoscopy quality measure correlating with detection of neoplasia

Authors: Marcin Romańczyk, Bartosz Ostrowski, Tomasz Marek, Tomasz Romańczyk, Małgorzata Błaszczyńska, Krzysztof Budzyń, Maciej Bugajski, Mateusz Koziej, Maciej Kajor, Krzysztof Januszewski, Wojciech Zajęcki, Marek Waluga, Marek Hartleb

Published in: Journal of Gastroenterology | Issue 7/2021

Login to get access

Abstract

Background

Esophagogastroduodenoscopy (EGD) is commonly used diagnostic method with no widely accepted quality measure. We assessed quality indicator—composite detection rate (CDR)—consisting of detection of at least one of the following: cervical inlet patch, gastric polyp and post-ulcer duodenal bulb deformation. The aim of the study was to validate CDR according to detection rate of upper gastrointestinal neoplasms (UGN).

Methods

It was a multicenter, prospective, observational study conducted from January 2019 to October 2019. The endoscopic reports from 2896 symptomatic patients who underwent diagnostic EGD were analyzed. The EGDs were performed in three endoscopy units located in tertiary university hospital, private outpatient clinic and local hospital.

Results

64 UGNs were detected. The mean CDR was 21.9%. The CDR correlated with UGN detection rate (R = 0.49, p = 0.045). Based on CDR quartiles, operators were divided into group 1 with CDR < 10%, group 2 with CDR 10–17%, group 3 with CDR 17.1–26%, and group 4 with CDR > 26%. Detection rate of UGN was significantly higher in the group 4 in comparison to group 1 (OR 4.4; 95% CI 2.2 − 9.0). In the multivariate regression model, patient age, male gender and operator’s CDR > 26% were independent risk factors of UGN detection (OR 1.03; 95% CI 1.01 − 1.05, OR 2; 95% CI 1.2 − 3.5, and OR 5.7 95% CI 1.5 − 22.3, respectively).

Conclusions

The CDR is associated with the detection of upper gastrointestinal neoplasms. This parameter may be a useful quality measure of EGD to be applied in general setting.
Literature
1.
go back to reference Peery AF, Crockett SD, Murphy CC, et al. Burden and cost of gastrointestinal, liver, and pancreatic diseases in the United States: update 2018. Gastroenterology. 2020;156:254–72.CrossRef Peery AF, Crockett SD, Murphy CC, et al. Burden and cost of gastrointestinal, liver, and pancreatic diseases in the United States: update 2018. Gastroenterology. 2020;156:254–72.CrossRef
2.
go back to reference Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424.PubMed Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424.PubMed
3.
go back to reference Jun JK, Choi KS, Lee HY, et al. Effectiveness of the Korean National Cancer Screening Program in reducing gastric cancer mortality. Gastroenterology. 2017;152:1319–28.CrossRef Jun JK, Choi KS, Lee HY, et al. Effectiveness of the Korean National Cancer Screening Program in reducing gastric cancer mortality. Gastroenterology. 2017;152:1319–28.CrossRef
4.
go back to reference Beg S, Ragunath K, Wyman A, et al. Quality standards in upper gastrointestinal endoscopy: a position statement of the British Society of Gastroenterology (BSG) and Association of Upper Gastrointestinal Surgeons of Great Britain and Ireland (AUGIS). Gut. 2017;66:1886–99.CrossRef Beg S, Ragunath K, Wyman A, et al. Quality standards in upper gastrointestinal endoscopy: a position statement of the British Society of Gastroenterology (BSG) and Association of Upper Gastrointestinal Surgeons of Great Britain and Ireland (AUGIS). Gut. 2017;66:1886–99.CrossRef
5.
go back to reference Bisschops R, Areia M, Coron E, et al. Performance measures for upper gastrointestinal endoscopy: a European Society of Gastrointestinal Endoscopy (ESGE) Quality Improvement Initiative. Endoscopy. 2016;48:843–64.CrossRef Bisschops R, Areia M, Coron E, et al. Performance measures for upper gastrointestinal endoscopy: a European Society of Gastrointestinal Endoscopy (ESGE) Quality Improvement Initiative. Endoscopy. 2016;48:843–64.CrossRef
6.
go back to reference Park WG, Shaheen NJ, Cohen J, et al. Quality indicators for EGD. Gastrointest Endosc. 2015;81:17–30.CrossRef Park WG, Shaheen NJ, Cohen J, et al. Quality indicators for EGD. Gastrointest Endosc. 2015;81:17–30.CrossRef
7.
go back to reference Pimenta-Melo AR, Monteiro-Soares M, Libânio D, et al. Missing rate for gastric cancer during upper gastrointestinal endoscopy: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol. 2016;28:1041–9.CrossRef Pimenta-Melo AR, Monteiro-Soares M, Libânio D, et al. Missing rate for gastric cancer during upper gastrointestinal endoscopy: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol. 2016;28:1041–9.CrossRef
8.
go back to reference Rodríguez de Santiago E, Hernanz N, Marcos-Prieto HM, et al. Rate of missed oesophageal cancer at routine endoscopy and survival outcomes: a multicentric cohort study. United Eur Gastroenterol J. 2019; 7:189–198. Rodríguez de Santiago E, Hernanz N, Marcos-Prieto HM, et al. Rate of missed oesophageal cancer at routine endoscopy and survival outcomes: a multicentric cohort study. United Eur Gastroenterol J. 2019; 7:189–198.
9.
go back to reference Kaminski MF, Thomas-Gibson S, Bugajski M, et al. Performance measures for lower gastrointestinal endoscopy: a European Society of Gastrointestinal Endoscopy (ESGE) quality improvement initiative. United Eur Gastroenterol J. 2017;5:309–34.CrossRef Kaminski MF, Thomas-Gibson S, Bugajski M, et al. Performance measures for lower gastrointestinal endoscopy: a European Society of Gastrointestinal Endoscopy (ESGE) quality improvement initiative. United Eur Gastroenterol J. 2017;5:309–34.CrossRef
10.
go back to reference Januszewicz W, Wieszczy P, Bialek A, et al. Endoscopist biopsy rate as a quality indicator for outpatient gastroscopy: a multicenter cohort study with validation. Gastrointest Endosc. 2019;89:1141–9.CrossRef Januszewicz W, Wieszczy P, Bialek A, et al. Endoscopist biopsy rate as a quality indicator for outpatient gastroscopy: a multicenter cohort study with validation. Gastrointest Endosc. 2019;89:1141–9.CrossRef
11.
go back to reference Park CH, Kim B, Chung H, et al. Endoscopic quality indicators for esophagogastroduodenoscopy in gastric cancer screening. Dig Dis Sci. 2014;60:38–46.CrossRef Park CH, Kim B, Chung H, et al. Endoscopic quality indicators for esophagogastroduodenoscopy in gastric cancer screening. Dig Dis Sci. 2014;60:38–46.CrossRef
12.
go back to reference Teh JL, Tan JR, Lau LJF, et al. Longer examination time improves detection of gastric cancer during diagnostic upper gastrointestinal endoscopy. Clin Gastroenterol Hepatol. 2015;13:480–7.CrossRef Teh JL, Tan JR, Lau LJF, et al. Longer examination time improves detection of gastric cancer during diagnostic upper gastrointestinal endoscopy. Clin Gastroenterol Hepatol. 2015;13:480–7.CrossRef
13.
go back to reference Park JM, Huo SM, Lee HH, et al. Longer observation time increases proportion of neoplasms detected by esophagogastroduodenoscopy. Gastroenteorlogy. 2017;153:460–9.CrossRef Park JM, Huo SM, Lee HH, et al. Longer observation time increases proportion of neoplasms detected by esophagogastroduodenoscopy. Gastroenteorlogy. 2017;153:460–9.CrossRef
14.
go back to reference Kawamura T, Wada H, Sakiyama N, et al. Examination time as a quality indicator of screening upper gastrointestinal endoscopy for asymptomatic examinees. Dig Endosc. 2017;29:569–75.CrossRef Kawamura T, Wada H, Sakiyama N, et al. Examination time as a quality indicator of screening upper gastrointestinal endoscopy for asymptomatic examinees. Dig Endosc. 2017;29:569–75.CrossRef
15.
go back to reference Gupta N, Gaddam S, Wani SB, et al. Longer inspection time is associated with increased detection of high-grade dysplasia and esophageal adenocarcinoma in Barrett’s esophagus. Gastrointest Endosc. 2012;76:531–8.CrossRef Gupta N, Gaddam S, Wani SB, et al. Longer inspection time is associated with increased detection of high-grade dysplasia and esophageal adenocarcinoma in Barrett’s esophagus. Gastrointest Endosc. 2012;76:531–8.CrossRef
16.
go back to reference Park JM, Lim CH, Cho YK, et al. The effect of photo-documentation of the ampulla on neoplasm detection rate during esophagogastroduodenoscopy. Endoscopy. 2019;51:115–24.CrossRef Park JM, Lim CH, Cho YK, et al. The effect of photo-documentation of the ampulla on neoplasm detection rate during esophagogastroduodenoscopy. Endoscopy. 2019;51:115–24.CrossRef
17.
go back to reference Song H, Ekheden IG, Zheng Z, et al. Incidence of gastric cancer among patients with gastric precancerous lesions: observational cohort study in a low risk Western population. BMJ. 2015;351:h3867.CrossRef Song H, Ekheden IG, Zheng Z, et al. Incidence of gastric cancer among patients with gastric precancerous lesions: observational cohort study in a low risk Western population. BMJ. 2015;351:h3867.CrossRef
18.
go back to reference Pimentel-Nunes P, Libânio D, Marcos-Pinto R, et al. Management of epithelial precancerous conditions and lesions in the stomach (MAPS II): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter and Microbiota Study Group (EHMSG), European Society of Pathology (ESP), and Sociedade Port. Endoscopy. 2019;51:365–88.CrossRef Pimentel-Nunes P, Libânio D, Marcos-Pinto R, et al. Management of epithelial precancerous conditions and lesions in the stomach (MAPS II): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter and Microbiota Study Group (EHMSG), European Society of Pathology (ESP), and Sociedade Port. Endoscopy. 2019;51:365–88.CrossRef
19.
go back to reference Gupta S, Li D, El Serag HB, et al. AGA clinical practice guidelines on management of gastric intestinal metaplasia. Gastroenterology. 2020;158:693–702.CrossRef Gupta S, Li D, El Serag HB, et al. AGA clinical practice guidelines on management of gastric intestinal metaplasia. Gastroenterology. 2020;158:693–702.CrossRef
20.
go back to reference Rusu R, Ishaq S, Wong T, et al. Cervical inlet patch: new insights into diagnosis and endoscopic therapy. Frontline Gastroenterol. 2018;9:214–20.CrossRef Rusu R, Ishaq S, Wong T, et al. Cervical inlet patch: new insights into diagnosis and endoscopic therapy. Frontline Gastroenterol. 2018;9:214–20.CrossRef
21.
go back to reference Bajbouj M, Meining A, Schmid RM. Endoscopic diagnosis and treatment of inlet patch: justification, techniques, and results. Tech Gastrointest Endosc. 2014;16:49–52.CrossRef Bajbouj M, Meining A, Schmid RM. Endoscopic diagnosis and treatment of inlet patch: justification, techniques, and results. Tech Gastrointest Endosc. 2014;16:49–52.CrossRef
22.
go back to reference Min JK, Cha JM, Kwak MS, et al. Quality indicators and outcome measures of endoscopy in the national cancer screening program. Yonsei Med J. 2019;60:1054–60.CrossRef Min JK, Cha JM, Kwak MS, et al. Quality indicators and outcome measures of endoscopy in the national cancer screening program. Yonsei Med J. 2019;60:1054–60.CrossRef
23.
go back to reference Hooi JKY, Lai WY, Ng WK, et al. Global prevalence of Helicobacter pylori infection: systematic review and meta-analysis. Gastroenterology. 2017;153:420–9.CrossRef Hooi JKY, Lai WY, Ng WK, et al. Global prevalence of Helicobacter pylori infection: systematic review and meta-analysis. Gastroenterology. 2017;153:420–9.CrossRef
24.
go back to reference Tacikowski T, Bawa S, Gajewska D, et al. Current prevalence of Helicobacter pylori infection in patients with dyspepsia treated in Warsaw. Poland Prz Gastroenterol. 2017;12:135–9.PubMed Tacikowski T, Bawa S, Gajewska D, et al. Current prevalence of Helicobacter pylori infection in patients with dyspepsia treated in Warsaw. Poland Prz Gastroenterol. 2017;12:135–9.PubMed
Metadata
Title
Composite detection rate as an upper gastrointestinal endoscopy quality measure correlating with detection of neoplasia
Authors
Marcin Romańczyk
Bartosz Ostrowski
Tomasz Marek
Tomasz Romańczyk
Małgorzata Błaszczyńska
Krzysztof Budzyń
Maciej Bugajski
Mateusz Koziej
Maciej Kajor
Krzysztof Januszewski
Wojciech Zajęcki
Marek Waluga
Marek Hartleb
Publication date
01-07-2021
Publisher
Springer Nature Singapore
Published in
Journal of Gastroenterology / Issue 7/2021
Print ISSN: 0944-1174
Electronic ISSN: 1435-5922
DOI
https://doi.org/10.1007/s00535-021-01790-3

Other articles of this Issue 7/2021

Journal of Gastroenterology 7/2021 Go to the issue